MedPlus Health Services Limited has announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a drug license at one of its stores located in Telangana. The suspension, issued by the Assistant Director of Drugs Control Administration in Warangal, affects the store on Parkal Main Road and will last for three days.
The order was received on 28 March 2026, following a violation under Rule 65 of the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The suspension is expected to result in a potential revenue loss of ₹0.60 lakh for the company.
This development has been disclosed in accordance with Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The details of the suspension will be available on the MedPlus Health Services website, as well as on the websites of the BSE Limited and the National Stock Exchange of India.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).
This article is written by Arunika Jain and reviewed by Aditya Bhagchandani before publication.